1. Home
  2. PEN vs CCCS Comparison

PEN vs CCCS Comparison

Compare PEN & CCCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • CCCS
  • Stock Information
  • Founded
  • PEN 2004
  • CCCS 1980
  • Country
  • PEN United States
  • CCCS United States
  • Employees
  • PEN N/A
  • CCCS N/A
  • Industry
  • PEN Medical/Dental Instruments
  • CCCS Computer Software: Prepackaged Software
  • Sector
  • PEN Health Care
  • CCCS Technology
  • Exchange
  • PEN Nasdaq
  • CCCS Nasdaq
  • Market Cap
  • PEN 9.1B
  • CCCS 7.4B
  • IPO Year
  • PEN 2015
  • CCCS N/A
  • Fundamental
  • Price
  • PEN $268.17
  • CCCS $11.27
  • Analyst Decision
  • PEN Buy
  • CCCS Buy
  • Analyst Count
  • PEN 16
  • CCCS 9
  • Target Price
  • PEN $262.87
  • CCCS $13.89
  • AVG Volume (30 Days)
  • PEN 423.0K
  • CCCS 3.8M
  • Earning Date
  • PEN 02-20-2025
  • CCCS 02-26-2025
  • Dividend Yield
  • PEN N/A
  • CCCS N/A
  • EPS Growth
  • PEN N/A
  • CCCS N/A
  • EPS
  • PEN 0.89
  • CCCS 0.07
  • Revenue
  • PEN $1,163,776,000.00
  • CCCS $926,937,000.00
  • Revenue This Year
  • PEN $13.55
  • CCCS $11.08
  • Revenue Next Year
  • PEN $14.48
  • CCCS $9.00
  • P/E Ratio
  • PEN $302.85
  • CCCS $160.28
  • Revenue Growth
  • PEN 16.96
  • CCCS 10.10
  • 52 Week Low
  • PEN $148.00
  • CCCS $9.79
  • 52 Week High
  • PEN $277.34
  • CCCS $12.88
  • Technical
  • Relative Strength Index (RSI)
  • PEN 68.37
  • CCCS 40.74
  • Support Level
  • PEN $237.65
  • CCCS $10.94
  • Resistance Level
  • PEN $260.88
  • CCCS $11.19
  • Average True Range (ATR)
  • PEN 9.75
  • CCCS 0.22
  • MACD
  • PEN 2.18
  • CCCS -0.03
  • Stochastic Oscillator
  • PEN 94.76
  • CCCS 37.02

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

About CCCS CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. The company generate revenue through the sale of software subscriptions and other revenue, primarily from professional services. The company has its presence in United States and China. Majority of the revenue is generated from United States.

Share on Social Networks: